Overdiagnosis of prostate cancer is prevalent due to detecting slow-growing, non-aggressive tumors that would not threaten a patient's life, resulting in unnecessary biopsies and treatments that affect quality of life.
Studies show a 30-50% overdiagnosis rate with PSA screening, leading to a substantial increase in detected cases that would not have caused harm if left undetected, emphasizing the burden of overdiagnosis.
Collection
[
|
...
]